Recent

% | $
Quotes you view appear here for quick access.

Medivation, Inc. Message Board

  • clsnphase3 clsnphase3 Sep 12, 2012 10:10 AM Flag

    CLSN = Biotech Name to Watch in Q4

    Celsion's Thermodox is in Phase 3 Liver Trials, and it has potential use in Breast & Lung Cancer treatment -- and all other Tumor treatments.

    This market cap should be MUCH higher. I know it's had a good quarter, but the fact of the matter is CLSN should never have lived in the $2-$3 range.

    It is smacking these tumors in a GOOD way. HEAT Trials/Data should show this. I think a # of Oncologists realize this is the FUTURE.

    I'm absolutely floored that very little realize the potential here. This is not an efficient market IMO. Revenues could be 1-2B annually.

    Do your DD ; Shorts are trying to stop this advance but I believe institutions will buy any dip. Don't get stopped. This stock is going much higher.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
MDVN
107.235+2.455(+2.34%)12:47 PMEDT